Study finds autoimmune diseases increase risk of mood disorders
People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or bipolar disorder, a new large-scale study says. Photo by Adobe Stock/HealthDay News
People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or bipolar disorder, a new large-scale study says.
The risk of mood disorders is 87% to 97% higher in people suffering from rheumatoid arthritis, inflammatory bowel disease, lupus, multiple sclerosis, psoriasis and Graves' syndrome, researchers reported Tuesday in the BMJ Mental Health.
This risk remains higher even after accounting for other factors like age, income and family history of psychiatric disorders, researchers found.
"Together, these results support the hypothesis that exposure to chronic inflammation may be associated with a greater risk for affective disorders," concluded the research team led by Arish Mudra Rakshasa-Loots with the University of Edinburgh Center for Clinical Brain Sciences in Britain.
For the study, researchers drew on data from 1.5 million people participating in a new large-scale British health study. Upon recruitment to the ongoing study, people provided a history of their physical and mental health.
In all, more than 37,800 of the study participants reported living with an autoimmune condition.
About 29% of people with an autoimmune illness said they'd been previously diagnosed with a mood disorder, compared with 18% of the general population, results show.
This included more than 25% versus 15% diagnosed with depression, and 21% versus nearly 13% diagnosed with anxiety.
Women with autoimmune diseases were particularly vulnerable to mood disorders, affecting 32% compared with 21% among men, results show.
"Theories suggest that sex hormones, chromosomal factors, and differences in circulating antibodies may partly explain these sex differences," researchers wrote.
Women with depression tend to have higher levels of inflammatory chemicals in their bloodstream, researchers noted.
"It is therefore possible that women may experience the compounding challenges of increased occurrence of autoimmunity and stronger effects of immune responses on mental health, resulting in the substantially higher prevalence of affective disorders observed in this study," the team wrote.
Given these results, it might be worth regularly checking people with an autoimmune disease for mood disorders, researchers concluded.
"Regular screening for mental health conditions may be integrated into clinical care for people who are diagnosed with autoimmune diseases, and especially women with these diagnoses, to enable early detection of affective disorders and delivery of tailored mental health interventions," researchers wrote.
Further studies should be done to determine other problems linked to autoimmune diseases -- like chronic pain, fatigue, sleep disruptions and social isolation - contribute to the risk for mood disorders, researchers added.
More information
The U.S. Pain Foundation has more on autoimmune diseases and mental health.
Copyright © 2025 HealthDay. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
6 hours ago
- UPI
Study: 1 in 5 U.S. food, drink products contain synthetic dyes
Synthetic food dyes are added to 1 in 5 packaged foods and drinks sold by top U.S. food manufacturers, a new study says. Photo by Adobe Stock/Zilong Zhang/HealthDay News Synthetic food dyes are added to 1 in 5 packaged foods and drinks sold by top U.S. food manufacturers, a new study says. The most common dye was Red 40, which was present in 1 out of 7 (14%) products, according to the paper published Wednesday in the Journal of the Academy of Nutrition and Dietetics. "Products containing synthetic dyes also had a much higher average total sugar content compared to products without synthetic dyes, suggesting that companies are using synthetic food dyes to market sweet foods and beverages," lead researcher Elizabeth Dunford said in a journal news release. She's a nutrition consultant with the University of North Carolina at Chapel Hill's Gillings Global School of Public Health. Red 40 is among eight synthetic dyes that U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has vowed to remove from the American food supply. The U.S. Food and Drug Administration (FDA) announced in April it was moving to revoke authorization for the dyes Citrus Red 2 and Orange B, and would work with industry to eliminate Red 40, Green 3, Yellow 5, Yellow 6, Blue 1 and Blue 2 from the food supply by the end of 2026. "These poisonous compounds offer no nutritional benefit and pose real, measurable dangers to our children's health and development," Kennedy said in an April news release. "That era is coming to an end." The new study shows how widespread these dyes have become at the supermarket, researchers said. For the study, researchers evaluated the ingredients in nearly 39,800 grocery store products produced by the top 25 U.S. food manufacturers, using a database that represents more than 80% of products sold in America. Children are more likely to be exposed to these dyes, results show. About 28% of products in the top five food categories marketed to children contained synthetic dyes, compared with 11% in the remaining categories. Those categories included confections, sugary beverages, ready-to-eat meals, breakfast cereals and baked goods. Sports drinks (79%), beverages made from concentrates (71%) and confections (54%) were the products most likely to contain synthetic dyes, researchers found. Carbonated beverages (30%), confections (26%) and sports drinks (14%) represented the lion's share of products containing synthetic dyes purchased by Americans. "We included sales data in our analysis of synthetic dye exposure, which may help to inform regulatory policies in this area," Dunford said. "Although certain food categories may contain more products with synthetic dyes, it is also important to consider what foods consumers are buying, as even food categories with smaller proportions of synthetic dyes may be purchased and consumed in significant amounts and thus contribute more to overall dietary intake of dyes," she added. On average, products with synthetic dyes also contained 141% more total sugar compared to offerings without the dyes, researchers said. But products with synthetic dyes had lower levels of sodium and saturated fat. "There are a number of policy options to limit dye exposure, including bans and warning labels," researcher Thomas Galligan said in a news release. He's principal scientist for food additives and supplements at the Center for Science in the Public Interest in Washington, D.C. "Companies can also voluntarily reduce the use of synthetic dyes in their products," he added. "Our results showing a range in companies' proportional use of dyes in many food categories suggests that reduction in use is readily feasible." More information The Center for Science in the Public Interest has more on the history of synthetic food dyes in the United States. Copyright © 2025 HealthDay. All rights reserved.
UPI
8 hours ago
- UPI
Study finds autoimmune diseases increase risk of mood disorders
People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or bipolar disorder, a new large-scale study says. Photo by Adobe Stock/HealthDay News People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or bipolar disorder, a new large-scale study says. The risk of mood disorders is 87% to 97% higher in people suffering from rheumatoid arthritis, inflammatory bowel disease, lupus, multiple sclerosis, psoriasis and Graves' syndrome, researchers reported Tuesday in the BMJ Mental Health. This risk remains higher even after accounting for other factors like age, income and family history of psychiatric disorders, researchers found. "Together, these results support the hypothesis that exposure to chronic inflammation may be associated with a greater risk for affective disorders," concluded the research team led by Arish Mudra Rakshasa-Loots with the University of Edinburgh Center for Clinical Brain Sciences in Britain. For the study, researchers drew on data from 1.5 million people participating in a new large-scale British health study. Upon recruitment to the ongoing study, people provided a history of their physical and mental health. In all, more than 37,800 of the study participants reported living with an autoimmune condition. About 29% of people with an autoimmune illness said they'd been previously diagnosed with a mood disorder, compared with 18% of the general population, results show. This included more than 25% versus 15% diagnosed with depression, and 21% versus nearly 13% diagnosed with anxiety. Women with autoimmune diseases were particularly vulnerable to mood disorders, affecting 32% compared with 21% among men, results show. "Theories suggest that sex hormones, chromosomal factors, and differences in circulating antibodies may partly explain these sex differences," researchers wrote. Women with depression tend to have higher levels of inflammatory chemicals in their bloodstream, researchers noted. "It is therefore possible that women may experience the compounding challenges of increased occurrence of autoimmunity and stronger effects of immune responses on mental health, resulting in the substantially higher prevalence of affective disorders observed in this study," the team wrote. Given these results, it might be worth regularly checking people with an autoimmune disease for mood disorders, researchers concluded. "Regular screening for mental health conditions may be integrated into clinical care for people who are diagnosed with autoimmune diseases, and especially women with these diagnoses, to enable early detection of affective disorders and delivery of tailored mental health interventions," researchers wrote. Further studies should be done to determine other problems linked to autoimmune diseases -- like chronic pain, fatigue, sleep disruptions and social isolation - contribute to the risk for mood disorders, researchers added. More information The U.S. Pain Foundation has more on autoimmune diseases and mental health. Copyright © 2025 HealthDay. All rights reserved.
New York Post
8 hours ago
- New York Post
Daily dose of baby aspirin can halve your chances of getting colorectal cancer if you have this condition
Could a pill a day keep polyps at bay? A new study suggests that a daily dose of aspirin could help ward off colorectal cancer in people with a rare genetic disorder that increases their risk of developing the disease. Better yet, British researchers found that low doses of the over-the-counter drug offer the same protection as higher ones — with fewer side effects. Advertisement 4 Several studies have linked long-term aspirin use to a lower risk of colorectal cancer and polyps. Stefan – The study involved nearly 1,900 people with Lynch syndrome, a hereditary condition that significantly raises the risk of several cancers, especially colorectal and endometrial. Though it affects an estimated 1.1 million Americans, fewer than 5% know they carry the genetic mutation, according to the National Cancer Institute. Advertisement Previous research found that a daily 600 milligram aspirin dose could cut colorectal cancer risk in people with Lynch syndrome by half. However, high doses can cause side effects like stomach pain, ulcers and bleeding, which have made some patients reluctant to continue with the preventive treatment. 4 Aspirin can cause uncomfortable side effects when taken at high doses. Liubomir – This time, scientists at Newcastle University in the UK split participants with Lynch syndrome into three groups, each taking 100mg, 300mg or 600mg of aspirin daily for five years. Advertisement By the end of the study, there were fewer colorectal cancer cases in all three groups, but those taking the lowest dose got the same protection with fewer side effects. 'We now have really good evidence that aspirin can prevent bowel cancer in those at a high risk of the disease,' said Dr. David Crosby, head of prevention and early detection research at Cancer Research UK. 4 Colorectal cancer is the second leading cause of cancer deaths in the US. Jo Panuwat D – Advertisement The average American's lifetime risk of colorectal cancer is about 5%, but those with Lynch syndrome face a staggering 40% to 80% risk, according to MD Anderson Cancer Center. The National Comprehensive Cancer Network recommends that people with Lynch syndrome take aspirin daily to reduce their chances of developing cancer. However, studies show only about 34% follow this advice — often due to concerns about side effects. 'Too many people are missing out on a potentially life-changing opportunity to prevent cancer,' said Sir John Burn, professor of clinical genetics at Newcastle University and lead author of the study. 'We have a chance to give more people with Lynch syndrome protection, which would reduce their fear of bowel cancer in the future.' 4 Lynch syndrome is passed down through families via a gene mutation. Dana Farber Cancer Institute Lynch syndrome is the most common cause of hereditary colorectal cancer in the US, with data showing that it accounts for about 3,800 cases each year. Advertisement Colon cancers tied to the genetic disorder tend to develop far faster than in the general population — often within one to two years versus about 10 years, according to the Cleveland Clinic. To make matters worse, those diagnosed with colorectal cancer linked to Lynch syndrome are more likely to face a relapse down the line. 'People with Lynch syndrome get regular colonoscopies and live with the anxiety that they are highly likely to develop bowel cancer in their lifetime,' Crosby said. 'Taking aspirin daily could cut this risk by at least half and alleviate their fears,' he added. Advertisement Once a disease that primarily affected older adults, colorectal cancer cases have surged among younger Americans in recent years. It's now the fourth most commonly diagnosed cancer in the US, and the second leading cause of cancer death nationwide, according to the Colorectal Cancer Alliance.
